Geode Capital Management’s Passage Bio PASG Stock Holding History
Bought
Maintained
Sold
Other funds holding PASG
LCM
IC
EAM
VA
Geode Capital Management's PASG Position: Q2 2026 in Review
Geode Capital Management reduced its Passage Bio (PASG) stake by 11% in Q2 2026, selling an estimated $27.2K and leaving 37,026 shares worth $181K. The position accounts for ﹤0.01% of the portfolio, ranked #3949.
Geode Capital Management first reported a position in PASG in Q2 2020 and has held it in 25 quarters since. The position peaked at $8.21M in Q4 2020. 28 funds tracked by Wall St. Rank hold PASG as of Q2 2026.
- Geode Capital Management held 37,026 shares of Passage Bio worth $181K as of Q2 2026.
- Geode Capital Management sold 4,354 Passage Bio shares in Q2 2026, an estimated $27.2K.
- Passage Bio made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #3949 holding.
- Geode Capital Management first reported a position in Passage Bio in Q2 2020 and has held it in 25 quarters since.
- Geode Capital Management's Passage Bio position peaked at $8.21M in Q4 2020.
- 28 funds tracked by Wall St. Rank held Passage Bio as of Q2 2026.
Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.